1.
Study Progression of Ursodeoxychlic acid (UDCA) in Treatment of Primary Biliary Cirrhosis for Primary Biliary Cirrhosis
熊去氧胆酸治疗原发性胆汁性肝硬化
2.
Surgical Treatment of Hepatolithiasis Associated with Secondary Biliary Cirrhosis;
肝胆管结石合并胆汁性肝硬化的外科治疗
3.
Clinical Analysis of Primary Biliary Cirrhosis: A Report of 78 Cases;
78例原发性胆汁性肝硬化的临床分析
4.
The Clinical Analysis of Primary Biliary Cirrhosis for 38 Cases;
原发性胆汁性肝硬化38例临床分析
5.
Clinical Analysis of 48 Cases with Primary Biliary Cirrhosis
48例原发性胆汁性肝硬化的临床分析
6.
Analysis of 21 Cases about Primary Biliary Cirrhosis
原发性胆汁性肝硬化21例临床分析
7.
Clinical Aanalysis of 48 Patients with Primary Biliary Cirrhosis
48例原发性胆汁性肝硬化临床分析
8.
Clinical characteristics of 38 cases with primary biliary cirrhosis
38例原发性胆汁性肝硬化的临床特征
9.
Clinical features in 25 patients with primary biliary cirrhosis(PBC)
25例原发性胆汁性肝硬化临床特征
10.
A Study on the Efficacy of Ursodeoxycholic Acid Combined Tongdan Decoction Treating 30 Patients with Primary Biliary Cirrhosis
熊去氧胆酸联合通胆汤治疗原发性胆汁性肝硬化研究
11.
Clinical and Pathological Characterization of 83 Ases of Primary Biliary Cirrhosis;
83例原发性胆汁性肝硬化临床及病理分析
12.
Clinical and Pathological Analysis of 21 Patients with Primary Biliary Cirrhosis
21例原发性胆汁性肝硬化临床资料与病理分析
13.
Progress in the study of osteoporosis in primary biliary cirrhosis
原发性胆汁性肝硬化并发骨质疏松的研究进展
14.
The Progress of Treatment and Pathogenesis of Primary Biliary Cirrhosis
原发性胆汁性肝硬化发病机制及治疗进展
15.
Research Progress in Immune pathogenesis of Primary Biliary Cirrhosis
原发性胆汁性肝硬化免疫发病机制的研究进展
16.
The relationship of Fas-670 polymorphisms with autoimmune liver disease hepatitis and primary cirrhosis
自身免疫性肝炎和原发性胆汁性肝硬化患者Fas-670基因多态性检测
17.
Clinical Analysis of Children with Congenital Biliary Dilatation of the Merger Biliary Cirrhosis;
小儿先天性胆管扩张症合并胆汁性肝硬化的临床分析
18.
Ursodeoxycholic Acid Intervention Primary Biliary Cirrhosis the Systematic of Review
熊去氧胆酸治疗原发性胆汁性肝硬化的系统评价